secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K/A
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001628280-25-054709
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 9.01, 2.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Critical Medical amends 8-K to include Keystone financials; acquisition closed
--------------------------------------------------------------------------------

- Acquisition of Keystone Perfusion Services closed Sep 16, 2025; all equity interests acquired.
- Keystone's audited FY2024: revenue $42.9M, net income $2.97M, total assets $16.9M.
- Amendment adds historical audited and unaudited financials of Keystone and pro forma combined statements.
- Sale of Passenger business to Joby Aero also referenced as part of overall transactions.
- Pro forma financials for FY2024, FY2023, and nine months ended Sep 30, 2025 filed as Exhibit 99.3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000162828025054709/0001628280-25-054709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000162828025054709/srta-20250916.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-054709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer